Recurrent and Metastatic Gastric Cancer
1 clinical trials · Condition
◉ Watch Recurrent and Metastatic Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients (NCT03026881) | Jiangsu HengRui Medicine Co., Ltd. | 2017-01-01 |
Track Recurrent and Metastatic Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.